Apolipoprotein A-I and serum amyloid a plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease

Haematologica

Volumn 95, Issue 9, 2010, Pages 1467-1472

  Tumblin, Ashaunta ^d   Tailor, Anitaben ^d   Hoehn, Gerard T ^a   Kyle Mack, A ^b   Mendelsohn, Laurel ^d   Freeman, Lita ^d   Xu, Xiuli ^d   Remaley, Alan T ^d   Munson, Peter J ^c   Suffredini, Anthony F ^a   Kato, Gregory J ^a,d  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE

Author keywords

Acute painful episode; Immunoassay; Sickle cell disease

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; HYDROXYUREA; LACTATE DEHYDROGENASE; PROTEIN;

ACUTE PAINFUL EPISODE; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOASSAY; PAIN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ANEMIA, SICKLE CELL; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; COHORT STUDIES; ENDOTHELIUM, VASCULAR; HUMANS; PAIN; PROTEOMICS; SERUM AMYLOID A PROTEIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77956797603     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.018044     Document Type: Article

References (37)

1. Ballas SK. Sickle cell disease: clinical management. Baillieres Clin Haematol. 1998;11(1):185-214.
2. Embury SH, Hebbel RP, Mohandas N, Steinburg MH. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press; 1994.
3. Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33(1):1-16.
4. Serjeant GR, Ceulaer CD, Lethbridge R, Morris J, Singhal A, Thomas PW. The painful crisis of homozygous sickle cell disease: clinical features. Br J Haematol. 1994; 87(3):586-591.
5. Bailey S, Higgs DR, Morris J, Serjeant GR. Is the painful crisis of sickle-cell disease due to sickling? Lancet. 1991;337(8743):735.
6. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11-16.
7. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive switching agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore). 1996;75(6):300-326.
8. Ballas SK, Lusardi M. Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance. Am J Hematol. 2005;79(1):17-25.
9. Dunlop RJ, Bennett KC. Pain management for sickle cell disease. Cochrane Database Syst Rev 2006(2): CD003350.
10. Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992;45(10): 902-906.
11. Stuart J, Stone PC, Akinola NO, Gallimore JR, Pepys MB. Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease. J Clin Pathol. 1994;47(2):166-169.
12. Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crisis. Br J Haematol. 1992;81(4):598-602.
13. Singhal A, Doherty JF, Raynes JG, McAdam KP, Thomas PW, Serjeant BE, et al. Is there an acute-phase response in steady-state sickle cell disease? Lancet. 1993;341(8846): 651-653.
14. Sabio H, McKie VC. Modified (mixed) erythrocyte sedimentation rate in sickle cell anemia. Clinical hemorheology 1992;587: 587-592.
15. Stuart J. Acute-phase response and sickle crisis. Lancet. 1993;341(8846):664.
16. Laogun AA, Ajayi NO, Osamo NO, Okafor LA. Plasma viscosity in sickle-cell anaemia. Clin Phys Physiol Meas. 1980;1:145-150.
17. Yuditskaya S, Tumblin A, Hoehn GT, Wang G, Drake SK, Xu X, et al. Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood. 2009;113(5):1122-1128.
18. Hassell KL, Eckman JR, Lane PA. Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes. The American journal of medicine. 1994;96(2):155-162.
19. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion. 2006;46(1):105-110.
20. Neely CL, Wajima T, Kraus AP, Diggs LW, Barreras L. Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am J Clin Pathol. 1969;52(2):167-169.
21. Hunt BJ, Korsah P, Eaton S, Brozovic M. Creatine kinase activity in sickle cell disease. J Clin Pathol. 1989;42(7):712-715.
22. Smith WR, Penberthy LT, Bovbjerg VE, McClish DK, Roberts JD, Dahman B, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94-101.
23. Akinola NO, Stevens SM, Franklin IM, Nash GB, Stuart J. Subclinical ischaemicepisodes during the steady state of sickle cell anaemia. J Clin Pathol. 1992;45(10): 902-906.
24. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995; 332(20):1317-1322.
25. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res. 2003;44(4):780-792.
26. Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141-212.
27. Artl A, Marsche G, Lestavel S, Sattler W, Malle E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol. 2000;20(3):763-772.
28. Billett HH, Nagel RL, Fabry ME. Paradoxical increase of painful crises in sickle cell patients with alpha-thalassemia. Blood. 1995;86(11):4382.
29. Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood. 1995;86(2): 776-783.
30. Cabana VG, Reardon CA, Wei B, Lukens JR, Getz GS. SAA-only HDL formed during the acute phase response in apoA-I+/+ andapoA-I-/- mice. J Lipid Res. 1999;40(6): 1090-1103.
31. Hosoai H, Webb NR, Glick JM, Tietge UJ, Purdom MS, de Beer FC, et al. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice. J Lipid Res. 1999;40(4):648-653.
32. Sasaki J, Waterman MR, Cottam GL. Decreased apolipoprotein A-I and B content in plasma of individuals with sickle cell anemia. Clin Chem. 1986;32(1 Pt 1):226-227.
33. Murray N, May A. Painful crises in sickle cell diseasepatients' perspectives. Bmj. 1988;297(6646):452-454.
34. Lowell CA, Stearman RS, Morrow JF. Transcriptional regulation of serum amyloid A gene expression. J Biol Chem. 1986;261(18):8453-8461.
35. Pruzanski W, Stefanski E, de Beer FC, de Beer MC, Ravandi A, Kuksis A. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J Lipid Res. 2000;41(7):1035-1047.
36. Machado RF, Mack AK, Martyr S, Barnett C, Macarthur P, Sachdev V, et al. Severity of pulmonary hypertension during vasoocclusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol. 2007;136(2):319-325.
37. Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, Ackerman AW, et al. L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. Circulation. 2003;107(18):2337-2341.